跳至主要内容
临床试验/NCT07556068
NCT07556068招募中不适用

Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring: a Multicenter, Prospective, Observational Study

Beijing Shijitan Hospital, Capital Medical University4 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2026年4月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
129
试验地点
4
主要终点
The sensitivity, specificity and area under the receiver operating characteristic curve for percentage of Modified Rankin scale 0-2

研究概览

简要总结

This multicenter, prospective, observational diagnostic accuracy study enrolls patients undergoing thrombectomy with intraoperative cerebral autoregulation monitoring and follows them up at predefined time points up to 90 days post-enrollment. The study aims to determine whether impaired cerebral autoregulation during thrombectomy can serve as an ultra-early biomarker for predicting futile recanalization in patients with acute ischemic stroke.

详细描述

Acute ischemic stroke (AIS) is the leading cause of death and disability in China. Landmark randomized controlled trials have demonstrated the benefit of endovascular therapy for patientswith acute stroke due to large-vessel occlusion. Despite successful recanalization rates exceeding 80%, more than half of patients fail to achieve functional independence following thrombectomy a phenomenon termed futile recanalization. Ultra-early identification of futile recanalization is critical for guiding individualized treatment strategies. Timely recognition of at-risk patients may enable targeted interventions - such as intra-arterial thrombolysis, rescue therapy, and neuroprotective measures that could potentially reverse unfavorable outcomes or mitigate adverse events. Monitoring cerebral autoregulation (CA) function during thrombectomy represents a promising approach for the ultra-early prediction of futile recanalization. This multicenter, prospective, observational diagnostic accuracy study aims to validate the hypothesis that intraoperative CA monitoring during thrombectomy can predict futile recanalization. A total of 129 participants will be enrolled and divided into a modeling cohort and a validation cohort. Participants will undergo face-to-face assessments at 24 ± 12 hours, 48 ± 12 hours, and 7 ± 3 days post-enrollment (or at discharge). A follow-up assessment will be conducted via telephone or in-person interview at 90 ± 7 days post-enrollment. The primary endpoints include the sensitivity, specificity, and area under the receiver operating characteristic curve of impaired CA for predicting futile recanalization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical signs consistent with acute ischemic stroke with large vessel occlusion in the anterior circulation (intracranial segment of the internal carotid artery, middle cerebral artery M1 segment) demonstrated with CTA/MRA/DSA.
  • NIHSS score ≥ 6 obtained prior to endovascular treatment.
  • Modified Rankin Scale ≤ 1 prior to qualifying stroke.
  • Acute ischemic stroke, undergone endovascular treatment within 24 hours of onset (time of stroke is the last known normal for wake-up stroke or with unknown onset time).with reaching the goal of mTICI grade 2b-3
  • For patients with symptom onset within 6 hours: ASPECTS ≥ 3; for patients with symptom onset between 6 and 24 hours: age ≤ 80 years and ASPECTS ≥
  • Patient/Legally Authorized Representative has signed the Informed Consent Form.

排除标准

  • Baseline CT/MRI confirms the presence of multiple vascular territory acute strokes.
  • Baseline CT/MRI confirms the presence of arterial dissection.
  • Evidence of intracranial hemorrhage or hemorrhagic transformation before thrombectomy.
  • Known allergies or intolerances to antiplatelet agents, anticoagulation drugs, iodinated contrast and/or anesthetics.
  • Severe infection (e.g. sepsis) or multiple organ failure.
  • Known hereditary or acquired hemorrhagic diathesis or coagulation factor deficiency; oral anticoagulant therapy with INR > 3; or use of a factor Xa inhibitor within the preceding 48 hours with an abnormal aPTT.
  • Baseline platelet count < 50 × 10^9/L.
  • Blood glucose concentration<50 mg/dL (2.7 mmol/L) or >400 mg/dL (22.2 mmol/L).
  • Refractory hypertension that is difficult to control by medication (Defined as persistent systolic blood pressure>185 mmHg or diastolic blood pressure>110 mmHg).
  • Severe cardiomyopathy with heart failure (LVEF ≤ 30% or NYHA class IV), acute myocardial infarction, or unstable angina.
  • Untreated moderate or severe coronary artery stenosis, or previous coronary artery bypass surgery.
  • Current hemodialysis or peritoneal dialysis; known severe renal insufficiency with estimated glomerular filtration rate < 30 mL/min or serum creatinine > 220 μmol/L (2.5 mg/dL).
  • Known intracranial aneurysm, and cerebral arteriovenous malformation.
  • Malignant brain tumor or CNS infection.
  • Pre-existing neurological or psychiatric disease that would confound the neurological or functional evaluations (e.g., dementia or mental illness)
  • Female who is pregnant or lactating at time of admission.
  • Anticipated life expectancy < 6 months.
  • Current participation in another investigational drug or device study.
  • local skin damage or other conditions that cannot cooperate with electrode sticking.
  • severe agitation or other conditions affecting data collection.

研究组 & 干预措施

Cerebral autoregulation monitoring cohort

The consecutively enrolled participants undergoing thrombectomy for acute ischemic stroke. Intraoperative cerebral autoregulation will be assessed using near-infrared spectroscopy (NIRS)-based cerebral oxygen saturation monitoring combined with continuous blood pressure monitoring (noninvasive or invasive). This cohort will be used to develop the predictive and validate model for futile recanalization.

干预措施: diagnostic accuracy study (Diagnostic Test)

结局指标

主要结局

The sensitivity, specificity and area under the receiver operating characteristic curve for percentage of Modified Rankin scale 0-2

时间窗: Month 3

"Futile recanalization" is defined as a poor neurological prognosis (90-day Modified Rankin scale \> 2) in patients with acute large vessel occlusion ischemic stroke who have achieved good recanalization grade (mTICI≥2b) after endovascular treatment. The sensitivity, specificity and area under the receiver operating characteristic curve of cerebral autoregulation coefficient in predicting the percentage of mRS scale 0-2 (Modified Rankin scale \[ranging from 0 (normal) to 6 (death) were calculated.

次要结局

  • The sensitivity, specificity and area under the receiver operating characteristic curve for early neurological improvement(Day 1)

研究者

发起方
Beijing Shijitan Hospital, Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shen Li

Professor

Beijing Shijitan Hospital, Capital Medical University

研究点 (4)

Loading locations...

相似试验